CN114210322A - 高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料及制备方法和应用 - Google Patents
高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料及制备方法和应用 Download PDFInfo
- Publication number
- CN114210322A CN114210322A CN202111570878.5A CN202111570878A CN114210322A CN 114210322 A CN114210322 A CN 114210322A CN 202111570878 A CN202111570878 A CN 202111570878A CN 114210322 A CN114210322 A CN 114210322A
- Authority
- CN
- China
- Prior art keywords
- moo
- wave
- absorbing material
- preparation
- crystal face
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910002900 Bi2MoO6 Inorganic materials 0.000 title claims abstract description 78
- 239000011358 absorbing material Substances 0.000 title claims abstract description 32
- 239000013078 crystal Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000002135 nanosheet Substances 0.000 claims abstract description 17
- 230000003197 catalytic effect Effects 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000015556 catabolic process Effects 0.000 claims description 19
- 238000006731 degradation reaction Methods 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- 229940088710 antibiotic agent Drugs 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 229910052797 bismuth Inorganic materials 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 150000001621 bismuth Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 5
- 239000002351 wastewater Substances 0.000 claims description 5
- 229910004619 Na2MoO4 Inorganic materials 0.000 claims description 4
- 150000002751 molybdenum Chemical class 0.000 claims description 4
- 239000011684 sodium molybdate Substances 0.000 claims description 4
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical group [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical class [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 2
- 238000001132 ultrasonic dispersion Methods 0.000 claims 1
- 239000004100 Oxytetracycline Substances 0.000 abstract description 22
- 229960000625 oxytetracycline Drugs 0.000 abstract description 21
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract description 21
- 235000019366 oxytetracycline Nutrition 0.000 abstract description 21
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract description 21
- 230000003115 biocidal effect Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 4
- 239000002957 persistent organic pollutant Substances 0.000 abstract description 4
- 238000004729 solvothermal method Methods 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 239000000178 monomer Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- KIPLYOUQVMMOHB-MXWBXKMOSA-L [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O Chemical compound [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O KIPLYOUQVMMOHB-MXWBXKMOSA-L 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940063650 terramycin Drugs 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/16—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
- B01J23/24—Chromium, molybdenum or tungsten
- B01J23/31—Chromium, molybdenum or tungsten combined with bismuth
-
- B01J35/23—
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
- B01J37/08—Heat treatment
- B01J37/10—Heat treatment in the presence of water, e.g. steam
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
- C02F1/302—Treatment of water, waste water, or sewage by irradiation with microwaves
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/725—Treatment of water, waste water, or sewage by oxidation by catalytic oxidation
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K9/00—Screening of apparatus or components against electric or magnetic fields
- H05K9/0073—Shielding materials
- H05K9/0081—Electromagnetic shielding materials, e.g. EMI, RFI shielding
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/34—Organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/34—Organic compounds containing oxygen
- C02F2101/345—Phenols
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/38—Organic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2305/00—Use of specific compounds during water treatment
- C02F2305/10—Photocatalysts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W10/00—Technologies for wastewater treatment
- Y02W10/30—Wastewater or sewage treatment systems using renewable energies
- Y02W10/37—Wastewater or sewage treatment systems using renewable energies using solar energy
Abstract
本发明涉及高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料及制备方法和应用。本发明通过简单的溶剂热法制备了具有特定{010}暴露面的二维Bi2MoO6纳米片,进一步水热在其侧面边缘定向原位生长零价态半金属Bi0,即可得到Bi0/Bi2MoO6{010}吸波材料。该材料在微波驱动下对抗生素类有机污染物土霉素(OTC)展现了超高的催化活性,在环境水体净化方面具有潜在的应用前景。
Description
技术领域
本发明属于吸波材料制备领域,具体的涉及一种高暴露{010}晶面的Bi0/Bi2MoO6吸波材料及其制备方法和应用。
背景技术
抗生素自问世以来,在人类对抗疾病的历程中起到了不可或缺的作用。然而,使用过程中部分抗生素不可避免地进入自然环境,会影响植物的正常生长,甚至导致细菌耐药性的增加。此外,抗生素类有机污染物土霉素(OTC)作为一种非常稳定的有机大分子,很难自然降解,伴随食物链进入人体后,严重威胁着人类的生命健康。因此,高效去除水体中抗生素污染物,创建清洁的水环境迫在眉睫,这也是关乎未来可持续发展的关键因素。
相比于传统的加热手段,微波加热速度更快,物料内外受热更加均匀,已被广泛应用于处理各类环境污染问题。微波与吸波材料相结合的催化技术,被用于高效诱导有机污染物的降解。
Bi2MoO6是一种层状结构的双金属氧化物,具有良好的吸波性能,近年来受到了广泛关注。Bi2MoO6微波催化活性与其形貌、组成、尺寸、暴露晶面等有关。文献报道表明,合适的暴露晶面可明显增强其催化活性。
发明内容
为了解决上述技术问题,本发明的目的之一是提供一种采用简单的溶剂热法制备高暴露{010}晶面诱导定向生长Bi0的Bi0/Bi2MoO6{010}吸波材料。
本发明的目的之二是提供Bi0/Bi2MoO6{010}吸波材料协同微波高效催化降解抗生素中的应用。
本发明采用的技术方案是:一种高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料,按质量百分比,Bi0占Bi2MoO6质量的5-20%。
一种高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料的制备方法,包括如下步骤:
1)Bi2MoO6{010}纳米片的制备:将铋盐、钼盐和CTAB(十六烷基三甲基溴化铵)溶解在去离子水中,剧烈搅拌30min后,用氨水调节pH=10,将所得混合物转移到反应釜中,水热反应后,用去离子水和乙醇清洗至中性,60℃干燥,得到Bi2MoO6{010}纳米片;
2)Bi0/Bi2MoO6{010}的制备:将铋盐溶解在乙二醇中,加入Bi2MoO6{010}纳米片,超声分散1h后,转移到反应釜中,水热反应后,洗涤,干燥,得到Bi0/Bi2MoO6{010}吸波材料。
进一步的,上述的制备方法,所述铋盐为Bi(NO3)3·5H2O。
进一步的,上述的制备方法,所述钼盐为Na2MoO4·2H2O。
进一步的,上述的制备方法,步骤1)中,所述水热反应为,140℃下反应24h。
进一步的,上述的制备方法,步骤2)中,铋盐中Bi和Bi2MoO6{010}纳米片的质量比为5-20%。
进一步的,上述的制备方法,步骤2)中,所述水热反应为,160℃反应12h。
本发明提供的高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料在降解废水中抗生素中的应用。
进一步的,方法如下:于含有抗生素的废水中加入Bi0/Bi2MoO6{010}吸波材料,控制微波功率为700W,催化降解。
本发明的有益效果是:本发明通过简单的溶剂热法制备了具有特定{010}暴露面的二维Bi2MoO6纳米片,零价态半金属Bi0高度定向生长在二维Bi2MoO6{010}纳米片边缘;MW驱动Bi0/Bi2MoO6{010}催化下,仅需5min,对OTC就展现了超高的催化去除效率。本发明Bi0/Bi2MoO6{010}吸波材料在微波驱动下对抗生素类有机污染物土霉素(OTC)展现了超高的催化活性,并在环境水体净化方面具有潜在的应用前景。
附图说明
图1是Bi2MoO6,Bi2MoO6{010},Bi0/Bi2MoO6{010}的XRD图谱。
图2是Bi2MoO6{010}的SEM图。
图3是Bi0/Bi2MoO6{010}的SEM图像(a)和TEM(b)图像。
图4是MW,Bi2MoO6{010},Bi0/Bi2MoO6{010}和Bi0/Bi2MoO6的微波催化氧化OTC性能对比。
图5是Bi2MoO6{010},Bi0/Bi2MoO6{010}和Bi0/Bi2MoO6的微波催化氧化OTC动力学。
具体实施方式
实施例1高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料(一)Bi0/Bi2MoO6{010}吸波材料,制备方法如下:
1、Bi2MoO6{010}纳米片的制备:
将Bi(NO3)3·5H2O(970mg,2mmol)、Na2MoO4·2H2O(242mg,1mmol)和CTAB(50mg,0.1mmol)溶解在40mL去离子水中,剧烈磁搅拌30min,形成非晶态白色沉淀,用氨水调节pH=10,将所得混合物转移到100mL的反应釜中,140℃下水热反应24h后,产物用去离子水和乙醇清洗至中性,60℃干燥12小时,得到Bi2MoO6{010}纳米片。
2、Bi0/Bi2MoO6{010}吸波材料的制备:
将Bi(NO3)3·5H2O(145.5mg,0.3mmol)溶解在40mL的乙二醇中,再加入Bi2MoO6{010}纳米片(418mg,0.7mmol),超声分散1h后,转移到100mL反应釜中,160℃水热反应12h后,所得产物洗涤,干燥,得到Bi0/Bi2MoO6{010}吸波材料。
(二)对比例——Bi2MoO6、Bi0/Bi2MoO6的制备:
将Bi(NO3)3·5H2O(970mg,2mmol)、Na2MoO4·2H2O(242mg,1mmol)和CTAB(50mg,0.1mmol)溶解在40mL去离子水中,剧烈磁搅拌30min,形成非晶态白色沉淀,将所得混合物转移到100mL的反应釜中,140℃下水热反应24h后,产物用去离子水和乙醇清洗至中性,60℃干燥12小时,得到Bi2MoO6材料。
将Bi(NO3)3·5H2O(145.5mg,0.3mmol)溶解在40mL的乙二醇中,再加入Bi2MoO6材料(418mg,0.7mmol),超声分散1h后,转移到100mL反应釜中,160℃水热反应12h后,所得产物洗涤,干燥,得到Bi0/Bi2MoO6材料。
(三)Bi0/Bi2MoO6{010}的表征
图1是Bi2MoO6,Bi2MoO6{010},Bi0/Bi2MoO6{010}的XRD图谱。由图1可知,通过水热直接合成的Bi2MoO6(未调pH)和本发明合成的Bi2MoO6{010}样品的XRD衍射峰均与PDFNo.21-0102标准图谱相匹配。其中,本发明合成的Bi2MoO6{010}样品结晶程度更高,并且,Bi2MoO6{010}样品的(060)晶面与(200)/(002)晶面的峰高比值显著提高,说明Bi2MoO6{010}样品高度暴露{010}晶面。在进一步水热得到的材料Bi0/Bi2MoO6{010}的XRD图谱中,可清晰地观察到Bi0(PDF No.44-1246)的衍射峰,说明零价态半金属Bi0被成功地沉积在了Bi2MoO6{010}纳米片上,并且暴露晶面没有明显变化。
图2是Bi2MoO6{010}的SEM图。由图2可见,Bi2MoO6{010}呈现2D纳米片结构,且表面及边缘均光滑。
图3为Bi0/Bi2MoO6{010}的SEM和TEM图。由图3中(a)Bi0/Bi2MoO6{010}的SEM图可见,纳米片的表面仍旧光滑,无明显沉积物,而其侧面边缘生长出极小的纳米粒子。由图3中(b)Bi0/Bi2MoO6{010}的TEM图也证明了这一点,说明在Bi0/Bi2MoO6{010}合成过程中Bi0的生长位置具有高选择性。
实施例2高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料在降解废水中抗生素中的应用
方法如下:
采用微波仪进行催化降解实验,其温度、功率、反应时间可控,并配有冷凝回流装置。
移取50mL 10mg·L-1土霉素(OTC)溶液于250mL的三口圆底烧瓶中,加入10mg的吸波材料,开启微波辐射(700W)。一定时间间隔取样后,溶液中OTC的含量采用紫外可见分光光度计进行监测。
1、不同降解方法对降解率的影响
方法如下:
移取50mL 10mg·L-1OTC溶液于250mL的三口圆底烧瓶中,如表1采用不同的降解方法:①加入10mg的Bi0/Bi2MoO6{010}吸波材料,吸附10min;②不加入吸波材料,开启微波辐射(700W),单独微波辐射5min;③加入10mg的Bi2MoO6{010}单体协同微波辐射(700W)5min;④加入10mg的Bi0/Bi2MoO6{010}单体协同微波辐射(700W)5min。结果如图4和表1。
表1不同方法对OTC降解效果对比
表1表明,Bi0/Bi2MoO6{010}对OTC单独吸附10min去除率仅为5.7%;单独微波辐射对OTC的降解作用几乎可以忽略。
图4表明,Bi2MoO6{010}单体在微波驱动下,5min内对OTC的氧化降解为37.0%;相同条件下,Bi0/Bi2MoO6{010}吸波材料对OTC的氧化降解效率可达93.4%,Bi0/Bi2MoO6对OTC降解效果为70.1%,说明在微波协同作用下,Bi0/Bi2MoO6{010}吸波材料展现了更高的催化活性。
由图5可见,本发明的催化过程符合准一级动力学模型,Bi2MoO6{010}与Bi0/Bi2MoO6{010}的反应速率常数k分别为0.096min-1和0.496min-1,Bi0/Bi2MoO6{010}吸波材料较Bi2MoO6{010}单体的反应速率提高了4.2倍。
2、Bi0/Bi2MoO6{010}用量对抗生素降解率的影响
方法:移取50mL 10mg·L-1OTC溶液于250mL的三口圆底烧瓶中,分别加入1mg,3mg,5mg,7mg,10mg和15mg的Bi0/Bi2MoO6{010},微波功率700W,辐射5min。结果如表2。
表2催化剂用量对OTC降解效果的影响
由表2可见,随着催化剂用量的增加,降解效率也随之增大。催化剂用量为10mg时,降解率可达到93.4%,进一步增加用量催化效率没有明显提升。
3、Bi0负载量对抗生素降解率的影响
将Bi(NO3)3·5H2O(970mg,2mmol)、Na2MoO4·2H2O(242mg,1mmol)和CTAB(50mg,0.1mmol)溶解在40mL去离子水中,剧烈磁搅拌30min,形成非晶态白色沉淀,用氨水调节pH=10,将所得混合物转移到100mL的反应釜中,140℃下水热反应24h后,产物用去离子水和乙醇清洗至中性,60℃干燥12小时,得到Bi2MoO6{010}纳米片。
分别取48.5mg,97mg,145.5mg,194mg Bi(NO3)3·5H2O溶解在40mL的乙二醇中,再加入418mg Bi2MoO6{010}纳米片,超声分散1h后,转移到100mL反应釜中,160℃水热反应12h后,所得产物洗涤,干燥,得到Bi0负载量分别为5%,10%,15%和20%的Bi0/Bi2MoO6{010}吸波材料。
移取50mL 10mg L-1OTC溶液于250mL的三口圆底烧瓶中,随后加入10mg不同Bi0负载量的Bi0/Bi2MoO6{010}吸波材料,并开启微波辐射(700W)辐射5min,结果如表3。
表3不同Bi0负载量对OTC降解效率的影响
由表3可见,微波辐射下,Bi0/Bi2MoO6{010}对OTC的催化氧化效果随着Bi0负载量的增加呈现先升高后降低的趋势,Bi0负载量为15%的催化剂在5min内对OTC的降解效率最佳。
Claims (9)
1.一种高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料,其特征在于,所述高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料,按质量百分比,Bi0占Bi2MoO6质量的5-20%。
2.一种高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料的制备方法,其特征在于,包括如下步骤:
1)Bi2MoO6{010}纳米片的制备:将铋盐、钼盐和CTAB溶解在去离子水中,剧烈搅拌30min后,用氨水调节pH=10,将所得混合物转移到反应釜中,水热反应后,用去离子水和乙醇清洗至中性,60℃干燥,得到Bi2MoO6{010}纳米片;
2)Bi0/Bi2MoO6{010}的制备:将铋盐溶解在乙二醇中,加入Bi2MoO6{010}纳米片,超声分散1h后,转移到反应釜中,水热反应后,洗涤,干燥,得到Bi0/Bi2MoO6{010}吸波材料。
3.根据权利要求2所述的制备方法,其特征在于,所述铋盐为Bi(NO3)3·5H2O。
4.根据权利要求2所述的制备方法,其特征在于,所述钼盐为Na2MoO4·2H2O。
5.根据权利要求2所述的制备方法,其特征在于,步骤1)中,所述水热反应为,140℃下反应24h。
6.根据权利要求2所述的制备方法,其特征在于,步骤2)中,铋盐中Bi和Bi2MoO6{010}纳米片的质量比为5-20%。
7.根据权利要求2所述的制备方法,其特征在于,步骤2)中,所述水热反应为,160℃反应12h。
8.权利要求1所述的高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料在降解废水中抗生素中的应用。
9.根据权利要求8所述的应用,其特征在于,方法如下:于含有抗生素的废水中加入Bi0/Bi2MoO6{010}吸波材料,控制微波功率为700W,催化降解。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111570878.5A CN114210322B (zh) | 2021-12-21 | 2021-12-21 | 高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料及制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111570878.5A CN114210322B (zh) | 2021-12-21 | 2021-12-21 | 高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料及制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114210322A true CN114210322A (zh) | 2022-03-22 |
CN114210322B CN114210322B (zh) | 2023-05-26 |
Family
ID=80704718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111570878.5A Active CN114210322B (zh) | 2021-12-21 | 2021-12-21 | 高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料及制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114210322B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107376900A (zh) * | 2017-07-26 | 2017-11-24 | 福州大学 | 钼酸铋超薄纳米片光催化材料的制备方法及其应用 |
CN108940261A (zh) * | 2018-06-22 | 2018-12-07 | 江苏大学 | 一种整合同质结与异质结复合光催化剂的制备方法及用途 |
CN110227443A (zh) * | 2019-05-07 | 2019-09-13 | 江苏诺菲泰安环境科技有限公司 | 一种量子点铋基光催化复合材料、制备方法及应用 |
CN112892562A (zh) * | 2021-01-28 | 2021-06-04 | 辽宁大学 | 基于原位合成法制备的Z型Bi3O4Cl/Bi2MoO6复合光催化剂及其应用 |
-
2021
- 2021-12-21 CN CN202111570878.5A patent/CN114210322B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107376900A (zh) * | 2017-07-26 | 2017-11-24 | 福州大学 | 钼酸铋超薄纳米片光催化材料的制备方法及其应用 |
CN108940261A (zh) * | 2018-06-22 | 2018-12-07 | 江苏大学 | 一种整合同质结与异质结复合光催化剂的制备方法及用途 |
CN110227443A (zh) * | 2019-05-07 | 2019-09-13 | 江苏诺菲泰安环境科技有限公司 | 一种量子点铋基光催化复合材料、制备方法及应用 |
CN112892562A (zh) * | 2021-01-28 | 2021-06-04 | 辽宁大学 | 基于原位合成法制备的Z型Bi3O4Cl/Bi2MoO6复合光催化剂及其应用 |
Non-Patent Citations (3)
Title |
---|
GUI YANG ET AL.: "Crystal defect-mediated {010} facets of Bi2MoO6 nanosheets for removal of TC: Enhanced mechanism and degradation pathway", 《APPLIED SURFACE SCIENCE》 * |
LILI ZHANG ET AL.: "Enhanced photocatalytic performance by the synergy of Bi vacancies and Bi0 in Bi0-Bi2-δMoO6", 《APPLIED CATALYSIS B: ENVIRONMENTAL》 * |
康勤书等: "(010)晶面暴露的Bi2MoO6纳米片对土霉素和四环素的可见光催化降解", 《华中农业大学学报》 * |
Also Published As
Publication number | Publication date |
---|---|
CN114210322B (zh) | 2023-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108479811B (zh) | 一种降解抗生素废水的z型声催化剂及其制备方法和应用 | |
Reheman et al. | Facile photo-ultrasonic assisted reduction for preparation of rGO/Ag2CO3 nanocomposites with enhanced photocatalytic oxidation activity for tetracycline | |
WO2021212923A1 (zh) | 负载于泡沫镍表面的 p-n 异质结复合材料及其制备方法与应用 | |
CN112337459A (zh) | 一种钨酸铋复合光催化剂的制备方法 | |
Salari et al. | Graphitic carbon nitride/reduced graphene oxide/silver oxide nanostructures with enhanced photocatalytic activity in visible light | |
CN110773204A (zh) | 一种S掺杂BiOBr纳米光催化剂及其制备和应用 | |
Yin et al. | Unique BiFeO 3/gC 3 N 4 mushroom heterojunction with photocatalytic antibacterial and wound therapeutic activity | |
CN103894171A (zh) | 一种花簇状氧化锌微米结构光催化剂的制备方法 | |
CN114522709B (zh) | 一种三维多孔石墨相氮化碳/碘氧化铋/银纳米粒子复合光催化剂及其制备方法和应用 | |
CN112010387A (zh) | 一种超声辅助棒状氧化锌光催化降解染料的方法 | |
Wu et al. | A novel core-shell Z-scheme heterojunction In2O3@ BiFeO3 with broad spectrum response for enhanced photocatalytic degradation of tetracycline | |
Wang et al. | In-situ metallic Bi deposited Bi12TiO20 with improved photocatalytic activity | |
Li et al. | Synthesizing ZnWO4 with enhanced performance in photoelectrocatalytic inactivating marine microorganisms | |
Ayappan et al. | Facile construction of a fascinating dual Z-scheme Bi2S3/tg-C3N4/α-Ag2WO4 photocatalyst for effective removal of organic pollutants: Influence factors, mechanism insight and degradation pathway | |
CN111686767B (zh) | 微球状Bi3O4Cl/BiOI复合物的制备及应用 | |
Jabbar et al. | Preparation of magnetic Fe3O4/g-C3N4 nanosheets immobilized with hierarchal Bi2WO6 for boosted photocatalytic reaction towards antibiotics in aqueous solution: S-type charge migration route | |
CN110935448B (zh) | 一种Ag纳米颗粒复合ZnO纳米棒阵列的制备方法 | |
CN114210322A (zh) | 高暴露{010}晶面的Bi0/Bi2MoO6{010}吸波材料及制备方法和应用 | |
CN110743575B (zh) | 一种具有吸附-光催化协同效应的AgIn5S8/SnS2固溶体催化剂的制备方法 | |
CN110813358A (zh) | 一种Ag2O-ZnO/g-C3N4光催化臭氧化催化剂的制备方法 | |
CN115722234A (zh) | 一种具有光动力-类酶活性的Ce-MoS2/WO3纳米复合抗菌材料的制备方法和应用 | |
CN113398954B (zh) | 一种BiOI/CdS复合光催化剂及其制备方法和应用 | |
CN115518649A (zh) | (CoCuZnMnMg)3O4高熵氧化物的制备方法 | |
CN111167479B (zh) | 一种四元可见光催化纳米复合材料的制备方法 | |
Yan et al. | Synthesize, construction and enhanced performance of Bi2WO6/ZnS heterojunction under visible light: experimental and DFT study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |